Free Trial

IO Biotech (IOBT) Insider Trading & Ownership

IO Biotech logo
$0.82 -0.07 (-7.87%)
(As of 11/15/2024 ET)

IO Biotech (NASDAQ:IOBT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.30%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$4,950.00
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$1.86 M
Get IOBT Insider Trade Alerts

Want to know when executives and insiders are buying or selling IO Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

IOBT Insider Buying and Selling by Quarter

IO Biotech Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/25/2024Holdings A/S NovoMajor ShareholderSell51,522$1.33$68,524.26  
5/10/2024Holdings A/S NovoMajor ShareholderSell658,809$1.22$803,746.98  
2/9/2024Holdings A/S NovoMajor ShareholderSell658,809$1.50$988,213.50  
11/21/2023Brian BurkavageCAOBuy5,000$0.99$4,950.00  
(Data available from 1/1/2013 forward)

IOBT Insider Trading Activity - Frequently Asked Questions

The list of insiders at IO Biotech includes Amy Sullivan, Brian Burkavage, Holdings A/S Novo, and Vivo Capital Ix, Llc. Learn more on insiders at IOBT.

2.30% of IO Biotech stock is owned by insiders. Learn more on IOBT's insider holdings.

The following insiders have purchased IOBT shares in the last 24 months: Amy Sullivan ($58,000.00), Brian Burkavage ($4,950.00), and Vivo Capital Ix, Llc ($5,999,998.60).

Insiders have purchased a total of 3,187,894 IOBT shares in the last 24 months for a total of $6,062,948.60 bought.

The following insider sold IOBT shares in the last 24 months: Holdings A/S Novo ($1,860,484.74).

Insiders have sold a total of 1,369,140 IO Biotech shares in the last 24 months for a total of $1,860,484.74 sold.

IO Biotech Key Executives

  • Dr. Mai-Britt Zocca Ph.D. (Age 56)
    Founder, President, CEO, Principal Financial Officer & Director
    Compensation: $892.24k
  • Mr. Devin Whittemore Smith (Age 56)
    Secretary, General Counsel & Chief Compliance Officer
    Compensation: $621.8k
  • Dr. Qasim Iftikhar Ahmad M.D. (Age 53)
    Chief Medical Officer
    Compensation: $503.28k
  • Prof. Inge Marie Svane M.D.
    Ph.D., Founder & Clinical Advisor
  • Prof. Mads Hald Andersen M.D.
    Ph.D., Founder & Scientific Advisor
  • Anders Ljungqvist
    Founder
  • Prof. Per Thor Straten
    Founder
  • Ms. Amy B. Sullivan M.B.A. (Age 53)
    Chief Financial Officer
    Compensation: $391.24k
  • Mr. Eric Faulkner M.B.A.
    Chief Technical Officer
  • Mr. Daniel G. Mannix Ph.D.
    Senior Vice President of Regulatory Affairs


This page (NASDAQ:IOBT) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners